2003, Research, Testimonials and Trials

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2003

Research

Testimonials

Trials

50-State Survey of State Court Decisions Supporting Expert-Related Judicial Gatekeeping

Drug & Device Law

JUNE 1, 2023

We think that they can, and for a state (like Pennsylvania and a number of others) that still follows the “ Frye ” standard looking to the “general acceptance” of expert testimony as the touchstone to admissibility, a Rule 702 state-law equivalent might look something like this: Rule 702. E.g. , Walsh v. BASF Corp. , 3d 446, 461 (Pa.

Testimonials

Testimonials Trials Science Government

The FDA and Feasible Alternative Designs

Drug & Device Law

FEBRUARY 20, 2023

2003), aff’d , 810 N.Y.S.2d That the product had been approved in “other countries” could not create a triable issue of fact because, even for other uses that the FDA eventually allowed, the necessary clinical trials had not been completed in 2010. His testimony is thus irrelevant and inadmissible. 2d 839, 851 (N.Y. 2006), app.

FDA

FDA FDA Approval Testimonials Vaccine

Drug Discovery Digest

50-State Survey of State Court Decisions Supporting Expert-Related Judicial Gatekeeping

The FDA and Feasible Alternative Designs

Stay Connected